Carol S Limbert Lerch, SPEECH THERAPIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1605 St Rt 60, Ste 3, Vermilion, OH 44089 Phone: 440-967-2508 Fax: 440-967-4023 |
Laura L Lloyd, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1605 St Rt 60, Ste 3, Vermilion, OH 44089 Phone: 440-967-2508 Fax: 440-967-4023 |
Mrs. Rhonda Lynn Prusak Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4210 Telegraph Ln, Vermilion, OH 44089 Phone: 440-967-1800 |
Mrs. Emily Elizabeth Divers, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4210 Telegraph Ln, Vermilion, OH 44089 Phone: 440-967-1800 |
Linda M Burke, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1605 St Rt 60, Ste 3, Vermilion, OH 44839 Phone: 440-967-2508 Fax: 440-967-4023 |
Thomas W Miller Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1605 St Rt 60, Ste 3, Vermilion, OH 44089 Phone: 440-967-2508 Fax: 440-967-4023 |
Kristin Sprague Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 935 Decatur St, Vermilion, OH 44089 Phone: 440-204-1703 |
Laura Moyer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1250 Sanford St, Vermilion, OH 44089 Phone: 440-204-1788 |
Alyssa Renae Melendez, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5355 Sailorway Dr, Vermilion, OH 44089 Phone: 440-204-1702 |
Melissa Bero Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1045 Riverside Dr, Vermilion, OH 44089 Phone: 440-552-7164 |
Allison Solberg Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1250 Sandford St, Vermilion, OH 44089 Phone: 419-357-1149 |
News Archive
SDI (Strategic Diagnostics Inc.), a provider of biotechnology-based products and services, and Fred Hutchinson Cancer Research Center (the Hutchinson Center) today jointly announced they will collaborate to discover biomarkers for use in the early detection of a variety of cancers.
St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and first U.S. implants of its Unify™ cardiac resynchronization therapy defibrillator (CRT-D) and Fortify™ implantable cardioverter defibrillator (ICD). The new devices feature advanced battery technology and circuitry that allow for the smallest device footprint in the industry and rapid charge times, without any compromise in device longevity or power.
Mild cognitive impairment, or MCI, may be one of Alzheimer's earliest signs. The subtle changes of MCI include problems with memory, language, thinking and judgment and a subjective sense that mental function is getting worse.
In Germany about 18 million people suffer from non-alcoholic fatty liver. The causes of this disease are manifold and include environmental as well as genetic factors.
› Verified 5 days ago